Elsevier is a world-leading publisher of scientific, technical and medical information, and serves more than 30 million scientists, students and health information professionals worldwide. For over 125 years, Elsevier has delivered world-class information and innovative tools to researchers, educators and practitioners. With a global scholarly community of 7,000 journal editors, 70,000 editorial board members, 300,000 reviewers, and 600,000 authors, Elsevier publishes over 2,000 journals and 19,000 books, with 2,000 new books each year.
The mission of Elsevier Health Sciences is to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. Serving 20 million allied health professionals, students, medical researchers, pharmaceutical companies, hospitals, and research institutions, Elsevier Health Sciences is passionate about publishing trusted, leading-edge medical information – pushing the frontiers and fuelling a continuous cycle of exploration, discovery and progress.
Elsevier Health Sciences is the publisher of key international journals for oncology, including Cancer Treatment Reviews, European Journal of Cancer, Lung Cancer, Seminars in Oncology, Seminars in Radiation Oncology, The Breast, The Lancet, and The Lancet Oncology.
Elsevier is uniquely equipped to serve the specific needs of clients in Asia, balancing regional expertise with global resources. As the leading professional organiser of medical, healthcare and pharmaceutical events, Elsevier manages numerous conferences and exhibitions that rank among the highest in its niche sectors worldwide.